Patent · US Active

Anti-CD83 antibodies and use thereof

US11725054B2 · kind B2 · utility

0Cited by
44References
22Claims
0Family size

Assignees

Inventors

Key dates

Filing dateJul 9, 2020
Grant dateAug 15, 2023
Priority date
Expiry dateApr 10, 2041

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2317/92
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present disclosure relates to proteins that bind to CD83 and uses thereof, for example, in therapy, prophylaxis, diagnosis, or prognosis.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.